The mucosa-associated lymphoid tissue lymphoma-translocation protein 1 (MALT1) is a key protein in the adaptive immune response system in humans. This protein is widely expressed in the human body and is related to nuclear factor-κB (NF-κB) signaling activation in response to T-cell receptors. Due to this, MALT1 is key in the regulation of inflammatory events in a variety of tissues, where its dysregulation is associated with several types of cancer, especially hematological cancers. In this sense, its relevance makes MALT1 a valuable target to treat many diseases, drawing the attention of many researchers with the aim of proposing new MALT1 inhibitors. However, there is a lack of literature describing its complex dynamical behavior and allosteric inhibition, which considerably hampers the computational design of new MALT1 allosteric inhibitors. In that regard, the present work investigated the complex conformational behavior of MALT1 protein during its allosteric inhibition. For this, biased molecular dynamics simulations, sophisticated machine learning techniques such as neural networks, and docking calculations were used. From the performed investigation, it was observed that through allosteric inhibition, Loop 1 and 3 movements were crucial to reduce the catalytic site cavity volume, keeping cysteine unavailable for substrate mimic binding. In addition, statistical information over the explored ensemble showed that the great majority of the inhibited conformations presented an unavailable catalytic cysteine for substrate binding. Hence, the presented results can be used as an objective criterion for the computational proposal of new MALT1 allosteric inhibitors. However, despite mouse MALT1 and human MALT1 presenting 93% homology, the generalization of the findings to human MALT1 protein should be taken with care, and the obtained results apply specifically to the mouse MALT1 construct.

Centre for Basic and Applied Research Faculty of Informatics and Management University of Hradec Králové Hradec Králové 500 03 Czech Republic

Laboratory of Molecular Modelling Department of Chemistry Federal University of Lavras Lavras 37200 000 Minas Gerais Brazil

Zobrazit více v PubMed

Sefer A. P., Abolhassani H., Ober F., Kayaoglu B., Bilgic Eltan S., Kara A., Erman B., Surucu Yilmaz N., Aydogmus C., Aydemir S., Charbonnier L.-M., Kolukisa B., Azizi G., Delavari S., Momen T., Aliyeva S., Kendir Demirkol Y., Tekin S., Kiykim A., Baser O. F., Cokugras H., Gursel M., Karakoc-Aydiner E., Ozen A., Krappmann D., Chatila T. A., Rezaei N., Baris S.. Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. J. Clin. Immunol. 2022;42:634–652. doi: 10.1007/s10875-021-01191-4. PubMed DOI

Ruland J., Hartjes L.. CARD–BCL-10–MALT1 signalling in protective and pathological immunity. Nat. Rev. Immunol. 2019;19:118–134. doi: 10.1038/s41577-018-0087-2. PubMed DOI

Brvar M., O’Neill T. J., Plettenburg O., Krappmann D.. An updated patent review of MALT1 inhibitors (2021-present) Expert Opin. Ther. Pat. 2025;35:639–656. doi: 10.1080/13543776.2025.2484371. PubMed DOI

Asaba K. N., Adachi Y., Tokumaru K., Watanabe A., Goto Y., Aoki T.. Structure-activity relationship studies of 3-substituted pyrazoles as novel allosteric inhibitors of MALT1 protease. Bioorg. Med. Chem. Lett. 2021;41:127996. doi: 10.1016/j.bmcl.2021.127996. PubMed DOI

Liang X., Cao Y., Li C., Yu H., Yang C., Liu H.. MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies. Medicinal Research Reviews. 2021;41:2388–2422. doi: 10.1002/med.21799. PubMed DOI

Gomez Solsona B., Schmitt A., Schulze-Osthoff K., Hailfinger S.. The Paracaspase MALT1 in Cancer. Biomedicines. 2022;10:344. doi: 10.3390/biomedicines10020344. PubMed DOI PMC

Isay S. E., Vornholz L., Schnalzger T., Groll T., Magg T., Loll P., Weirich G., Steiger K., Hauck F., Ruland J.. Enforced CARD11/MALT1 signaling in dendritic cells triggers hemophagocytic lymphohistiocytosis. Proc. Natl. Acad. Sci. U. S. A. 2024;121:e2413162121. doi: 10.1073/pnas.2413162121. PubMed DOI PMC

Seshadri M. R., Melnick A. M.. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leuk. Lymphoma. 2022;63:789–798. doi: 10.1080/10428194.2021.1999444. PubMed DOI

Mempel T. R., Krappmann D.. Combining precision oncology and immunotherapy by targeting the MALT1 protease. J. Immunother. Cancer. 2022;10:e005442. doi: 10.1136/jitc-2022-005442. PubMed DOI PMC

Kurden-Pekmezci A., Cakiroglu E., Eris S., Mazi F. A., Coskun-Deniz O. S., Dalgic E., Oz O., Senturk S.. MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growth. Life Sciences. 2023;323:121690. doi: 10.1016/j.lfs.2023.121690. PubMed DOI

Rosenbaum M., Gewies A., Pechloff K., Heuser C., Engleitner T., Gehring T., Hartjes L., Krebs S., Krappmann D., Kriegsmann M., Weichert W., Rad R., Kurts C., Ruland J.. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nat. Commun. 2019;10:2352. doi: 10.1038/s41467-019-10203-2. PubMed DOI PMC

Di Pilato M., Kim E. Y., Cadilha B. L., Prüßmann J. N., Nasrallah M. N., Seruggia D., Usmani S. M., Misale S., Zappulli V., Carrizosa E., Mani V., Ligorio M., Warner R. D., Medoff B. D., Marangoni F., Villani A.-C., Mempel T. R.. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112–116. doi: 10.1038/s41586-019-1215-2. PubMed DOI PMC

Flynn S. M., Chen C., Artan M., Barratt S., Crisp A., Nelson G. M., Peak-Chew S.-Y., Begum F., Skehel M., de Bono M.. MALT-1 mediates IL-17 neural signaling to regulate C. elegans behavior, immunity and longevity. Nat. Commun. 2020;11:2099. doi: 10.1038/s41467-020-15872-y. PubMed DOI PMC

Kip E., Staal J., Tima H. G., Verstrepen L., Romano M., Lemeire K., Suin V., Hamouda A., Baens M., Libert C., Kalai M., Van Gucht S., Beyaert R.. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mic. Journal of Virology. 2018;92:n/a. doi: 10.1128/JVI.00720-18. PubMed DOI PMC

Zhang R.-Y., Wang Z.-X., Zhang M.-Y., Wang Y.-F., Zhou S.-L., Xu J.-L., Lin W.-X., Ji T.-R., Chen Y.-D., Lu T., Li N.-G., Shi Z.-H.. MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies. J. Med. Chem. 2025;68:5075–5096. doi: 10.1021/acs.jmedchem.4c02873. PubMed DOI

Unnerståle S., Nowakowski M., Baraznenok V., Stenberg G., Lindberg J., Mayzel M., Orekhov V., Agback T.. Backbone Assignment of the MALT1 Paracaspase by Solution NMR. PLoS One. 2016;11:e0146496. doi: 10.1371/journal.pone.0146496. PubMed DOI PMC

Trivedi R., Nagarajaram H. A.. Intrinsically Disordered Proteins: An Overview. International Journal of Molecular Sciences. 2022;23:14050. doi: 10.3390/ijms232214050. PubMed DOI PMC

Babu M. M.. The contribution of intrinsically disordered regions to protein function, cellular complexity, and human disease. Biochem. Soc. Trans. 2016;44:1185–1200. doi: 10.1042/BST20160172. PubMed DOI PMC

Kletzien O. A., Wuttke D. S., Batey R. T.. J. Mol. Biol. 2024;436:168702. doi: 10.1016/j.jmb.2024.168702. PubMed DOI PMC

Jones A. N., Graß C., Meininger I., Geerlof A., Klostermann M., Zarnack K., Krappmann D., Sattler M.. Modulation of pre-mRNA structure by hnRNP proteins regulates alternative splicing of MALT1. Science Advances. 2022;8:eabp9153. doi: 10.1126/sciadv.abp9153. PubMed DOI PMC

Guo H.-B., Huntington B., Perminov A., Smith K., Hastings N., Dennis P., Kelley-Loughnane N., Berry R.. AlphaFold2 modeling and molecular dynamics simulations of an intrinsically disordered protein. PLoS One. 2024;19:e0301866. doi: 10.1371/journal.pone.0301866. PubMed DOI PMC

Aupič J., Pokorná P., Ruthstein S., Magistrato A.. Predicting Conformational Ensembles of Intrinsically Disordered Proteins: From Molecular Dynamics to Machine Learning. J. Phys. Chem. Lett. 2024;15:8177–8186. doi: 10.1021/acs.jpclett.4c01544. PubMed DOI

Coskuner-Weber O.. Structures prediction and replica exchange molecular dynamics simulations of α-synuclein: A case study for intrinsically disordered proteins. Int. J. Biol. Macromol. 2024;276:133813. doi: 10.1016/j.ijbiomac.2024.133813. PubMed DOI

Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R., Rueda D., Gaide O., Guzzardi M., Iancu E. M., Rufer N., Fasel N., Thome M.. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 2008;9:272–281. doi: 10.1038/ni1568. PubMed DOI

Wiesmann C., Leder L., Blank J., Bernardi A., Melkko S., Decock A., D’Arcy A., Villard F., Erbel P., Hughes N., Freuler F., Nikolay R., Alves J., Bornancin F., Renatus M.. Structural Determinants of MALT1 Protease Activity. J. Mol. Biol. 2012;419:4–21. doi: 10.1016/j.jmb.2012.02.018. PubMed DOI

Schiesser S., Hajek P., Pople H. E., Käck H., Öster L., Cox R. J.. Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors. Eur. J. Med. Chem. 2022;227:113925. doi: 10.1016/j.ejmech.2021.113925. PubMed DOI

Hughes N., Erbel P., Bornancin F., Wiesmann C., Schiering N., Villard F., Decock A., Rubi B., Melkko S., Spanka C., Buschmann N., Pissot-Soldermann C., Simic O., Beerli R., Sorge M., Tintelnot-Blomley M., Beltz K., Régnier C. H., Quancard J., Schlapbach A., Langlois J.-B., Renatus M.. Stabilizing Inactive Conformations of MALT1 as an Effective Approach to Inhibit Its Protease Activity. Adv. Ther. (Weinh.) 2020;3:2000078. doi: 10.1002/adtp.202000078. DOI

Zhang J., Ren L., Wang Y., Fang X.. In silico study on identification of novel MALT1 allosteric inhibitors. RSC Adv. 2019;9:39338–39347. doi: 10.1039/C9RA07036B. PubMed DOI PMC

Quancard J., Klein T., Fung S.-Y., Renatus M., Hughes N., Israël L., Priatel J. J., Kang S., Blank M. A., Viner R. I., Blank J., Schlapbach A., Erbel P., Kizhakkedathu J., Villard F., Hersperger R., Turvey S. E., Eder J., Bornancin F., Overall C. M.. An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nat. Chem. Biol. 2019;15:304–313. doi: 10.1038/s41589-018-0222-1. PubMed DOI

Wallerstein J., Han X., Levkovets M., Lesovoy D., Malmodin D., Mirabello C., Wallner B., Sun R., Sandalova T., Agback P., Karlsson G., Achour A., Agback T., Orekhov V.. Insights into mechanisms of MALT1 allostery from NMR and AlphaFold dynamic analyses. Commun. Biol. 2024;7:868. doi: 10.1038/s42003-024-06558-y. PubMed DOI PMC

Schlauderer F., Seeholzer T., Desfosses A., Gehring T., Strauss M., Hopfner K.-P., Gutsche I., Krappmann D., Lammens K.. Molecular architecture and regulation of BCL10-MALT1 filaments. Nat. Commun. 2018;9:4041. doi: 10.1038/s41467-018-06573-8. PubMed DOI PMC

Zhang G.. Advancing DFT predictions in Cu-chalcogenides with full-yet-shallow 3d-orbitals: Meta-GGA plus Hubbard-like U correction. J. Chem. Phys. 2024;161:174109. doi: 10.1063/5.0232711. PubMed DOI

Sisk T. R., Robustelli P.. Folding-upon-binding pathways of an intrinsically disordered protein from a deep Markov state model. Proceedings of the National Academy of Sciences. 2024;121:e2313360121. doi: 10.1073/pnas.2313360121. PubMed DOI PMC

Liu J., Liu X., Zhang T., Huang J., Tang B. Z., Chau Y.. Metastable biological matter in liquid phase separation. Applied Research. 2024;3:e202300071. doi: 10.1002/appl.202300071. DOI

Andolpho G. A., Ramalho T. C.. Pnictogen bond-driven control of the molecular interaction between organophosphorus and acetylcholinesterase enzyme. J. Comput. Chem. 2024;45:1303–1315. doi: 10.1002/jcc.27328. PubMed DOI

Tavares C. A., Santos T. M. R., da Cunha E. F. F., Ramalho T. C.. Molecular Dynamics-Assisted Interaction of Vanadium Complex–AMPK: From Force Field Development to Biological Application for Alzheimer’s Treatment. J. Phys. Chem. B. 2023;127:495–504. doi: 10.1021/acs.jpcb.2c07147. PubMed DOI

Gonçalves M. A., Gonçalves A. S., Franca T. C. C., Santana M. S., da Cunha E. F. F., Ramalho T. C.. Improved Protocol for the Selection of Structures from Molecular Dynamics of Organic Systems in Solution: The Value of Investigating Different Wavelet Families. J. Chem. Theory Comput. 2022;18:5810–5818. doi: 10.1021/acs.jctc.2c00593. PubMed DOI

Ramalho T. C., Bühl M.. Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers. Magn. Reson. Chem. 2005;43:139–146. doi: 10.1002/mrc.1514. PubMed DOI

Ramalho T. C., Taft C. A.. Thermal and solvent effects on the NMR and UV parameters of some bioreductive drugs. J. Chem. Phys. 2005;123:054319. doi: 10.1063/1.1996577. PubMed DOI

Invernizzi M., Piaggi P. M., Parrinello M.. Unified Approach to Enhanced Sampling. Phys. Rev. X. 2020;10:041034. doi: 10.1103/PhysRevX.10.041034. DOI

Novelli P., Bonati L., Pontil M., Parrinello M.. Characterizing Metastable States with the Help of Machine Learning. J. Chem. Theory Comput. 2022;18:5195–5202. doi: 10.1021/acs.jctc.2c00393. PubMed DOI

Invernizzi M., Parrinello M.. Rethinking Metadynamics: From Bias Potentials to Probability Distributions. J. Phys. Chem. Lett. 2020;11:2731–2736. doi: 10.1021/acs.jpclett.0c00497. PubMed DOI

Rizzi V., Aureli S., Ansari N., Gervasio F. L.. OneOPES, a Combined Enhanced Sampling Method to Rule Them All. J. Chem. Theory Comput. 2023;19:5731–5742. doi: 10.1021/acs.jctc.3c00254. PubMed DOI PMC

Gangwal A., Lavecchia A.. AI-Driven Drug Discovery for Rare Diseases. J. Chem. Inf. Model. 2025;65:2214–2231. doi: 10.1021/acs.jcim.4c01966. PubMed DOI

Rizzi V., Bonati L., Ansari N., Parrinello M.. The role of water in host-guest interaction. Nat. Commun. 2021;12:93. doi: 10.1038/s41467-020-20310-0. PubMed DOI PMC

Ansari N., Rizzi V., Parrinello M.. Water regulates the residence time of Benzamidine in Trypsin. Nat. Commun. 2022;13:5438. doi: 10.1038/s41467-022-33104-3. PubMed DOI PMC

Santos R. M., Ramalho T. C.. Molecular Dynamic-Assisted Interaction Between HABT and PI3K Enzyme: Exploring Metastable States for Promising Cancer Diagnosis Applications. J. Comput. Chem. 2025;46:e70080. doi: 10.1002/jcc.70080. PubMed DOI PMC

Hanwell M. D., Curtis D. E., Lonie D. C., Vandermeersch T., Zurek E., Hutchison G. R.. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 2012;4:17. doi: 10.1186/1758-2946-4-17. PubMed DOI PMC

Vanommeslaeghe K., Hatcher E., Acharya C., Kundu S., Zhong S., Shim J., Darian E., Guvench O., Lopes P., Vorobyov I., Mackerell A. D.. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 2010;31:671–690. doi: 10.1002/jcc.21367. PubMed DOI PMC

Abraham, M. ; Alekseenko, A. ; Bergh, C. ; Blau, C. ; Briand, E. ; Doijade, M. ; Fleischmann, S. ; Gapsys, V. ; Garg, G. ; Gorelov, S. ; Gouaillardet, G. ; Gray, A. ; Eric Irrgang, M. ; Jalalypour, F. ; Jordan, J. ; Junghans, C. ; Kanduri, P. ; Keller, S. ; Kutzner, C. ; Lemkul, J. A. ; Lundborg, M. ; Merz, P. ; Miletić, V. ; Morozov, D. ; Páll, S. ; Schulz, R. ; Shirts, M. ; Shvetsov, A. ; Soproni, B. ; van der Spoel, D. ; Turner, P. ; Uphoff, C. ; Villa, A. ; Wingbermühle, S. ; Zhmurov, A. ; Bauer, P. ; Hess, B. ; Lindahl, E. . GROMACS 2023 Source code, 2023.

Huang J., Rauscher S., Nawrocki G., Ran T., Feig M., de Groot B. L., Grubmüller H., MacKerell A. D.. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods. 2017;14:71–73. doi: 10.1038/nmeth.4067. PubMed DOI PMC

Tribello G. A., Bonomi M., Branduardi D., Camilloni C., Bussi G.. PLUMED 2: New feathers for an old bird. Comput. Phys. Commun. 2014;185:604–613. doi: 10.1016/j.cpc.2013.09.018. DOI

Bonati L., Piccini G., Parrinello M.. Deep learning the slow modes for rare events sampling. Proceedings of the National Academy of Sciences. 2021;118:e2113533118. doi: 10.1073/pnas.2113533118. PubMed DOI PMC

Pérez-Hernández G., Paul F., Giorgino T., De Fabritiis G., Noé F.. Identification of slow molecular order parameters for Markov model construction. J. Chem. Phys. 2013;139:015102. doi: 10.1063/1.4811489. PubMed DOI

Noé F., Clementi C.. Collective variables for the study of long-time kinetics from molecular trajectories: theory and methods. Curr. Opin. Struct. Biol. 2017;43:141–147. doi: 10.1016/j.sbi.2017.02.006. PubMed DOI

Schwantes C. R., Pande V. S.. Improvements in Markov State Model Construction Reveal Many Non-Native Interactions in the Folding of NTL9. J. Chem. Theory Comput. 2013;9:2000–2009. doi: 10.1021/ct300878a. PubMed DOI PMC

Bonati L., Trizio E., Rizzi A., Parrinello M.. A unified framework for machine learning collective variables for enhanced sampling simulations: mlcolvar. J. Chem. Phys. 2023;159:014801. doi: 10.1063/5.0156343. PubMed DOI

Paszke, A. ; Gross, S. ; Massa, F. ; Lerer, A. ; Bradbury, J. ; Chanan, G. ; Killeen, T. ; Lin, Z. ; Gimelshein, N. ; Antiga, L. ; Desmaison, A. ; Köpf, A. ; Yang, E. ; DeVito, Z. ; Raison, M. ; Tejani, A. ; Chilamkurthy, S. ; Steiner, B. ; Fang, L. ; Bai, J. ; Chintala, S. . PyTorch: An Imperative Style, High-Performance Deep Learning Library. In Proceedings of the 33rd International Conference on Neural Information Processing Systems; Curran Associates Inc.: Red Hook, NY, USA, 2019.

Falcon, W. ; Borovec, J. ; Wälchli, A. ; Eggert, N. ; Schock, J. ; Jordan, J. ; Skafte, N. ; Bereznyuk, V. ; Harris, E. ; Murrell, T. ; Yu, P. ; Præsius, S. ; Addair, T. ; Zhong, J. ; Lipin, D. ; Uchida, S. ; Bapat, S. ; Schröter, H. ; Dayma, B. ; Karnachev, A. ; Kulkarni, A. ; Komatsu, S. ; Martin, B. ; Schiratti, J.-B. ; Mary, H. ; Byrne, D. ; Eyzaguirre, C. ; cinjon; Bakhtin, A. . PyTorchLightning/pytorch-lightning: Version 0.7.6; Zenodo, 2020. 10.5281/zenodo.3828935. DOI

Kozakov D., Hall D. R., Xia B., Porter K. A., Padhorny D., Yueh C., Beglov D., Vajda S.. The ClusPro web server for protein–protein docking. Nat. Protoc. 2017;12:255–278. doi: 10.1038/nprot.2016.169. PubMed DOI PMC

Jones G., Jindal A., Ghani U., Kotelnikov S., Egbert M., Hashemi N., Vajda S., Padhorny D., Kozakov D.. Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Acta Crystallographica Section D. 2022;78:690–697. doi: 10.1107/S2059798322002741. PubMed DOI PMC

Ravindranath P. A., Forli S., Goodsell D. S., Olson A. J., Sanner M. F.. AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLoS Comput. Biol. 2015;11:e1004586. doi: 10.1371/journal.pcbi.1004586. PubMed DOI PMC

Abadi, M. , et al. TensorFlow: Large-Scale Machine Learning on Heterogeneous Systems, 2015. https://www.tensorflow.org/ (accessed 2025-12-11).

Berman H., Henrick K., Nakamura H.. Announcing the worldwide Protein Data Bank. Nature Structural & Molecular Biology. 2003;10:n/a. doi: 10.1038/nsb1203-980. PubMed DOI

Xu Y., Wang S., Hu Q., Gao S., Ma X., Zhang W., Shen Y., Chen F., Lai L., Pei J.. CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res. 2018;46:W374–W379. doi: 10.1093/nar/gky380. PubMed DOI PMC

Wang S., Xie J., Pei J., Lai L.. CavityPlus 2022 Update: An Integrated Platform for Comprehensive Protein Cavity Detection and Property Analyses with User-friendly Tools and Cavity Databases. J. Mol. Biol. 2023;435:168141. doi: 10.1016/j.jmb.2023.168141. PubMed DOI